mRNA based vaccines provide broad protection against different SARS-CoV-2 variants of concern

In order to overcome the pandemic of COVID-19, messenger RNA (mRNA)-based vaccine has been extensively researched as a rapid and versatile strategy. Herein, we described the immunogenicity of mRNA-based vaccines for Beta and the most recent Omicron variants. The homologous mRNA-Beta and mRNA-Omicron...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haomeng, Chen, Zhao, Wang, Zhenghua, Li, Jin, Yan, Zhihong, Yuan, Jinbo, Zhu, Airu, Chen, Lan, Liu, Ye, Hu, Chenlong, Zhu, Ali, Li, Guowei, Li, Yuehu, Deng, Jie, Ma, Liqiao, Sui, Xiuwen, Miao, Wei, Li, Junqiang, Zheng, Xiuyu, Piao, Jinhua, Yao, Yanfeng, Rao, Juhong, Shan, Chao, Yuan, Zhiming, Zhao, Jincun, Zhu, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176361/
https://www.ncbi.nlm.nih.gov/pubmed/35604772
http://dx.doi.org/10.1080/22221751.2022.2081616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176361/
https://www.ncbi.nlm.nih.gov/pubmed/35604772
http://dx.doi.org/10.1080/22221751.2022.2081616

Ejemplares similares